EUVIMEDEUVIMED entdecken
Crossref

Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience

Bernarda Patiño Araujo iD, Karla Elizabeth Duque Jácome iD, María Emilia Salgado Báez iD, Gabriel Villavicencio Logroño iD, Napoleón Salgado Macías iD

Clinical Obesity · 2025-02 · 15 (1)

DOI: 10.1111/cob.12705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Obesity, online erschienen am 22.09.2024. Verfasst von Bernarda Patiño Araujo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clínica Bariátrica Dr. Napoleón Salgado, Quito, Ecuador. Hauptthemen laut MEDLINE: Gastric Balloon, Body Composition, Weight Loss. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People with excess weight and obesity compose 64.5% of the Ecuadorian population. The Allurion Intragastric Balloon (IGB) is a noninvasive weight loss alternative for patients ineligible for other bariatric procedures. The impact of the procedure on weight loss and body composition, along with insertion complications and secondary effects were investigated. This is a single‐centre retrospective study of patients who underwent Allurion IGB insertion from July 2020 to March 2021. This study followed 167 patients for 12 months after EIGB insertion. Our sample had a mean initial weight of 83.6 ± 13.8 kg and initial body mass index of 31.3 ± 3.6 kg/m 2 . Percentage total weight loss was 4.65% ± 0.56%, 8.5% ± 4%, 12.29% ± 4.65%, 15.68% ± 5.22%, 17.14% ± 6.05%, and 14.68% ± 18.02% for months 1, 2, 3, 4, 6 and 12, respectively. In the fourth month, 92 patients (56.4%) had lost ≥50% excess body weight; at month 6, 104 patients (67.5%) achieved this goal. Regarding body composition, body fat percentage started at 38.99% ± 7.92%, and at month 6 was 35.67% ± 6.84%, this was the only significance in the statistical analysis.This study aligns with the literature's safety and efficacy results for the Allurion IGB while illustrating the need for further research regarding weight behaviour after its expulsion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric BalloonBody CompositionWeight LossHumansFemaleMaleEcuadorRetrospective StudiesAdultMiddle AgedObesity, MorbidBody WeightBody Mass IndexObesityTreatment Outcome

Stichwörter der Autor:innen

AllurionEcuadorIntragastric balloonbariatric

Autor:innen und Institutionen

  • Clínica Bariátrica Dr. Napoleón Salgado, Quito, Ecuador.
  • Cochrane Central Executive Team, Cochrane Geographic Groups and Fields, Oakham, UK.

ORCID-Profile: Bernarda Patiño Araujo, Karla Elizabeth Duque Jácome, María Emilia Salgado Báez, Gabriel Villavicencio Logroño, Napoleón Salgado Macías

Zitieren

APA

Patiño Araujo, B., Duque Jácome, K. E., Salgado Báez, M. E., Villavicencio Logroño, G., & Salgado Macías, N. (2025). Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience. Clinical Obesity, 15(1). https://doi.org/10.1111/cob.12705

Vancouver

Patiño Araujo B, Duque Jácome KE, Salgado Báez ME, Villavicencio Logroño G, Salgado Macías N. Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience. Clinical Obesity. 2025;15(1). doi:10.1111/cob.12705

BibTeX
@article{PatioAraujo2025,
  author = {Patiño Araujo, Bernarda and Duque Jácome, Karla Elizabeth and Salgado Báez, María Emilia and Villavicencio Logroño, Gabriel and Salgado Macías, Napoleón},
  title = {Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience},
  journal = {Clinical Obesity},
  year = {2025},
  volume = {15},
  number = {1},
  doi = {10.1111/cob.12705}
}
Kostenlos starten →